Here’s Why I Haven’t Sold Aurora Cannabis (TSX:ACB) Stock

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) remains cheap but not valuable. Yet I’m still going to hold onto it for now, and here’s why.

Before I begin, I want to be clear: I do not think Aurora Cannabis (TSX: ACB)(NYSE:ACB) is a buy today. I’m going to dig into the company and look clearly at the company’s fundamentals and outlook. But deciding that it’s a buy and deciding it’s a sell are two very different things. While I won’t be increasing my stake, I’m not selling it either. Let me explain why.

The highs and lows

Aurora stock had a solid run before the cannabis crash in 2018. The company was touted as the largest producer of cannabis at the time and the cheapest. Management boasted of bringing the cost to cultivate cannabis down to below $1 per gram, all while others were $4 or more!

But the problem for Aurora was shareholder dilution. The company didn’t, and still doesn’t, have a partner to help funds its research, development, and growth. Instead, the company diluted shareholder funds to pay for its growth. It also remains a leader in the global medical marijuana market but less so in the recreational sector, even with 50% of gross sales coming from recreational cannabis. It also lacks the United States foothold so many others have attempted to edge in on with federal legalization a major possibility.

All of this has led Aurora to the fraction of where it once was. And it may get worse. While the company’s cost-saving methods are great today, this could soon change. The Canadian producer will soon have to battle against future production entrants from countries with cheap labour, such as Portugal, Denmark, and Uruguay. And with the U.S. as the largest potential cannabis market, Aurora is still no where in sight on the THC front. While its entrance in over 20 other countries will help drive a path to profitability, it will still certainly miss out.

Fundamental performance

So, that’s where Aurora has been, and here’s where it is today. The company’s most recently quarterly performance has left much to be desired. Revenue was up 23% year over year, but also reported a net loss of $302 million — almost triple what it was the quarter before. The company also failed to deliver on a a promised positive EBITDA by the end of the fiscal second quarter 2021. Analysts now don’t see any cost-cutting or growth path that could deliver a near-term positive EBITDA.

Shares are still down by 34% in the last year, and the company currently has a price-to-sales ratio of eight, and price-to-book ratio of one, which is cheap but not valuable. It has $675 million in debt with profit still far off.

So, why hold?

Here at the Fool, we recommend long-term holding. Aurora Cannabis stock is still a major player in the cannabis industry. While again, I do not think that buying it right now is the right move, I don’t think selling for a loss is the right move either. At this point, the company can produce a massive amount of cannabis around the world. While it won’t be expanding any time soon, it will continue to produce cannabis at a cheap cost and work towards profitability.

When profitability does come, shares will increase. Even now, analysts estimate that the price target is triple where it is today. While there is still too much risk to have me increase my stake, I’ll simply wait it out until I can get out at the right time. While this stock isn’t likely to be a long-term hold forever, it could simply be a wait and see for investors currently holding the stock.

Fool contributor Amy Legate-Wolfe owns shares of Aurora Cannabis.

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

Top Canadian Stocks to Buy Right Now With $1,000

Cannara, Source Energy and CareRx just updated investors. See what $1,000 can buy in these Canadian stocks, plus the risks…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

This Cannabis Stock Jumped 12% in a Day: The Math Says Be Careful

Tilray's record revenue came with declining cannabis sales and negative free cash flow, making the investment much more speculative than…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf’s Takeover Bid for Aurora Cannabis: What Investors Need to Know

Curaleaf's takeover bid for Aurora Cannabis offers a premium but brings stock, debt, and deal risks. Here’s what ACB investors…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors.

It's appealing directly to the Canadian company's shareholders with a cash-and-stock offer.

Read more »

runner checks her biodata on smartwatch
Cannabis Stocks

Average TFSA and RRSP Balances at Age 45: Are You on Par?

Most 45-year-olds have less than $100,000 combined in their TFSA and RRSP. Here's how TerrAscend could help you close the…

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Risky Stocks That Could Send Your $100,000 Investment to $0

Cannabis stocks look risky because price wars, dilution, and regulation can turn one weak quarter into a long drawdown.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

My Biggest Investing Regret in 2025 Was Buying This Stock

Canopy Growth is a cautionary reminder to buy businesses, not headlines, especially in hype-driven sectors like cannabis.

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg.

Read more »